Matrix search results

Effectiveness bank home page. Opens new window Matrix search results

You have found 219 entries after clicking on a search link (usually the MORE information link) in a matrix cell. Sorted by the main topic addressed, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Re-order the list by the most recently added or updated entries or by the most recently published documents


If you have not found what you want you could:
Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or recent bulletins.
Documents are regularly added. Use the e-mail update service to monitor additions.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo Drug and Alcohol Findings logo



STUDY 2011 HTM file
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Together studies recently conducted across the UK suggest that consistent participation in methadone maintenance treatment plus adequate access to fresh injecting equipment has prevented many hepatitis C infections, supporting calls for needle exchange to be expanded and methadone treatment sustained.

REVIEW 2012 HTM file
Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review

A review reporting on the results of six trials from the UK, USA and Australia finds that – at least on their own – interventions such as counselling and peer-educator training have not prevented injecting drug users becoming infected with hepatitis C.

STUDY 2014 HTM file
Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions

A combination of needle exchange, methadone maintenance and a shift away from injecting meant that between 2008 and 2012, 1000 fewer Scottish injectors had to face chronic infection with the potentially deadly hepatitis C virus.

STUDY 2012 HTM file
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland

National survey of injectors attending services supplying injecting equipment suggests methadone maintenance plus an abundant supply of needles and syringes help protect Scottish injectors from infection by hepatitis C.

STUDY 2015 HTM file
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

Using data pooled from studies in three countries, researchers examined the impact of hepatitis C testing and counselling – and of testing positive versus negative – on whether people who inject drugs become more or less likely to risk infection.

STUDY 2015 HTM file
Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

In the UK context, this study’s findings imply that to prevent new cases it is best to focus expensive new treatments for hepatitis C infection on injectors who infrequently share their injecting equipment – patients most likely to be found and recruited via needle exchanges and addiction treatment services.

HOT TOPIC 2017 HTM file
Hepatitis C ‘giant’ still growing

One of our selection of hot topics – important issues which sometimes generate heated debate. For a time it seemed impossible to reverse the epidemic of injecting-related hepatitis C infection. Now we know that aided by new treatments which clear the infection, it can be done – but will we?

STUDY 2017 HTM file
Recovery of infectious hepatitis C virus from injection paraphernalia: implications for prevention programs serving people who inject drugs

Resources spent on supplying ‘cookers’ and filters at needle exchanges may not help curb the spread of hepatitis C. Laboratory simulation suggests infections thought to be have been spread by sharing this equipment may be a proxy for transmission that occurs due to sharing blood-contaminated equipment for dividing drugs.

DOCUMENT 2021 HTM file
Wound aware: a resource for commissioners and providers of drug services

People who inject drugs are at risk of serious and potentially life-threatening wounds. In new guidance, Public Health England describes how drug services can be ‘wound aware’ by adopting three key characteristics.

STUDY 2018 HTM file
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings – what is required to achieve the WHO’s HCV elimination targets?

What would it take for the UK to meet the World Health Organization’s target of a 90% reduction in hepatitis C by 2030? According to projections in three diverse areas, current levels of harm reduction services are averting a great deal of transmission, and adding only moderate rates of treatment for hepatitis C would put Britain on course to achieve the elimination target.


Select search results page

PREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22